Wolverine Trading
LABD icon

Wolverine Trading’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Wolverine Trading’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$871K Buy
21,000
+19,360
+1,180% +$1.12M ﹤0.01% 3045
2025
Q2 		$122K Buy
1,640
+270
+20% +$23.9K ﹤0.01% 4113
2025
Q1 		$116K Sell
1,370
-2,290
-63% -$168K ﹤0.01% 4179
2024
Q4 		$267K Buy
+3,660
New +$224K ﹤0.01% 4164
2024
Q3 		– Sell
-4,500
Closed -$330K – 5116
2024
Q2 		$330K Buy
4,500
+1,010
+29% +$85.2K ﹤0.01% 3284
2024
Q1 		$254K Buy
+3,490
New +$291K ﹤0.01% 3540
2023
Q4 		– Sell
-6,400
Closed -$1.32M – 4875
2023
Q3 		$1.32M Sell
6,400
-1,460
-19% -$237K ﹤0.01% 1898
2023
Q2 		$1.15M Buy
7,860
+580
+8% +$86.6K ﹤0.01% 1902
2023
Q1 		$1.59M Sell
7,280
-2,270
-24% -$386K ﹤0.01% 1534
2022
Q4 		$1.65M Buy
9,550
+3,110
+48% +$637K ﹤0.01% 1513
2022
Q3 		$1.57M Buy
+6,440
New +$1.5M ﹤0.01% 1588
2022
Q1 		– Sell
-4,780
Closed -$1.19M – 5968
2021
Q4 		$1.19M Sell
4,780
-760
-14% -$175K ﹤0.01% 2424
2021
Q3 		$1.19M Buy
5,540
+2,270
+69% +$483K ﹤0.01% 2774
2021
Q2 		$627K Sell
3,270
-2,370
-42% -$531K ﹤0.01% 3370
2021
Q1 		$1.41M Buy
5,640
+2,180
+63% +$423K ﹤0.01% 2316
2020
Q4 		$817K Buy
3,460
+30
+0.9% +$11.4K ﹤0.01% 2610
2020
Q3 		$2.02M Buy
3,430
+3,251
+1,816% +$2.1M ﹤0.01% 1471
2020
Q2 		$129K Buy
179
+22
+14% +$27.6K ﹤0.01% 4042
2020
Q1 		$431K Sell
157
-407
-72% -$1.16M ﹤0.01% 2825
2019
Q4 		$1.42M Buy
+564
New +$2M ﹤0.01% 2105

Other funds holding LABD

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

Wolverine Trading's LABD Position: Q3 2023 in Review

Wolverine Trading sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q3 2023, closing a stake of 1,225 shares — an estimated $199K sold.

Wolverine Trading first reported a position in LABD in Q4 2019 and held it in 9 quarters. The position peaked at $910K in Q1 2020. 16 funds tracked by Wall St. Rank hold LABD as of Q3 2023.

  • Wolverine Trading reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q3 2023 after selling out during the quarter.
  • Wolverine Trading sold 1,225 Direxion Daily S&P Biotech Bear 3X ETF shares in Q3 2023, an estimated $199K.
  • Wolverine Trading first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q4 2019 and held it in 9 quarters.
  • Wolverine Trading's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $910K in Q1 2020.
  • 16 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q3 2023.

Based on Wolverine Trading's 13F filing for Q3 2023, filed 15 Nov 2023.